10-Q 1 d10q.htm FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2004 Form 10-Q for Period Ended September 30, 2004
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2004

 

or

 

¨ Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from              to             

 

Commission File Number 001-15811

 


 

MARKEL CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Virginia   54-1959284
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. employer
identification number)

 

4521 Highwoods Parkway, Glen Allen, Virginia 23060-6148

(Address of principal executive offices)

(Zip code)

 

(804) 747-0136

(Registrant’s telephone number, including area code)

 

NONE

(Former name, former address and former fiscal year,

if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Number of shares of the registrant’s common stock outstanding at October 29, 2004: 9,847,253

 



Table of Contents

Markel Corporation

Form 10-Q

Index

 

          Page Number

PART I. FINANCIAL INFORMATION

    

Item 1. Financial Statements

    
    

Consolidated Balance Sheets— September 30, 2004 and December 31, 2003

   3
    

Consolidated Statements of Operations and Comprehensive Income (Loss)— Quarters and Nine Months Ended September 30, 2004 and 2003

   4
    

Consolidated Statements of Changes in Shareholders’ Equity— Nine Months Ended September 30, 2004 and 2003

   5
    

Consolidated Statements of Cash Flows— Nine Months Ended September 30, 2004 and 2003

   6
    

Notes to Consolidated Financial Statements

   7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   14
    

Critical Accounting Policies

   14

Item 3. Quantitative and Qualitative Disclosures About Market Risk

   19

Item 4. Controls and Procedures

   20

Safe Harbor and Cautionary Statement

   20

PART II. OTHER INFORMATION

    

Item 6. Exhibits

   21

Signatures

   22

Exhibit Index

   23

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Balance Sheets

 

     September 30,
2004


    December 31,
2003


 
     (dollars in thousands)  

ASSETS

                

Investments, available-for-sale, at estimated fair value:

                

Fixed maturities (amortized cost of $4,171,190 in 2004 and $3,840,339 in 2003)

   $ 4,267,467     $ 3,926,652  

Equity securities (cost of $755,752 in 2004 and $638,445 in 2003)

     1,088,883       968,777  

Short-term investments (estimated fair value approximates cost)

     205,533       82,012  
    


 


Total Investments, Available-For-Sale

     5,561,883       4,977,441  
    


 


Cash and cash equivalents

     356,623       372,511  

Receivables

     464,458       450,920  

Reinsurance recoverable on unpaid losses

     1,618,605       1,614,114  

Reinsurance recoverable on paid losses

     112,637       156,493  

Deferred policy acquisition costs

     211,887       200,284  

Prepaid reinsurance premiums

     182,589       213,403  

Intangible assets

     342,617       357,317  

Other assets

     243,204       189,750  
    


 


Total Assets

   $ 9,094,503     $ 8,532,233  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY

                

Unpaid losses and loss adjustment expenses

   $ 5,347,851     $ 4,929,713  

Unearned premiums

     1,069,305       1,060,188  

Payables to insurance companies

     94,654       150,159  

Convertible notes payable (estimated fair value of $111,000 in 2004 and $99,000 in 2003)

     93,829       90,601  

Senior long-term debt (estimated fair value of $660,000 in 2004 and $562,000 in 2003)

     609,761       521,510  

Junior Subordinated Deferrable Interest Debentures (estimated fair value of $165,000 in 2004 and $153,000 in 2003)

     150,000       150,000  

Other liabilities

     223,153       247,783  
    


 


Total Liabilities

     7,588,553       7,149,954  
    


 


Shareholders’ equity:

                

Common stock

     741,978       737,356  

Retained earnings

     486,794       375,041  

Accumulated other comprehensive income

                

Net unrealized holding gains on fixed maturities and equity securities, net of tax expense of $150,293 in 2004 and $145,826 in 2003

     279,115       270,819  

Cumulative translation adjustments, net of tax benefit of $1,043 in 2004 and $505 in 2003

     (1,937 )     (937 )
    


 


Total Shareholders’ Equity

     1,505,950       1,382,279  

Commitments and contingencies

                
    


 


Total Liabilities and Shareholders’ Equity

   $ 9,094,503     $ 8,532,233  
    


 


 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Operations and Comprehensive Income (Loss)

 

     Quarter Ended
September 30,


    Nine Months Ended
September 30,


 
     2004

    2003

    2004

    2003

 
     (dollars in thousands, except per share data)  

OPERATING REVENUES

                                

Earned premiums

   $ 521,985     $ 475,995     $ 1,542,803     $ 1,347,221  

Net investment income

     51,222       46,379       147,910       137,079  

Net realized gains (losses) from investment sales

     (253 )     (7,360 )     6,937       35,843  
    


 


 


 


Total Operating Revenues

     572,954       515,014       1,697,650       1,520,143  
    


 


 


 


OPERATING EXPENSES

                                

Losses and loss adjustment expenses

     381,802       378,868       1,009,930       938,820  

Underwriting, acquisition and insurance expenses

     169,255       147,102       491,012       420,895  

Amortization of intangible assets

     —         —         —         4,127  
    


 


 


 


Total Operating Expenses

     551,057       525,970       1,500,942       1,363,842  
    


 


 


 


Operating Income (Loss)

     21,897       (10,956 )     196,708       156,301  

Interest expense

     14,495       13,720       40,317       38,756  
    


 


 


 


Income (Loss) Before Income Taxes

     7,402       (24,676 )     156,391       117,545  

Income tax expense (benefit)

     (6,423 )     (8,143 )     41,253       38,790  
    


 


 


 


Net Income (Loss)

   $ 13,825     $ (16,533 )   $ 115,138     $ 78,755  
    


 


 


 


OTHER COMPREHENSIVE INCOME (LOSS)

                                

Unrealized gains (losses) on securities, net of taxes:

                                

Net holding gains (losses) arising during the period

   $ 56,133     $ (13,224 )   $ 12,805     $ 82,705  

Less reclassification adjustments for gains (losses) included in net income (loss)

     165       4,784       (4,509 )     (23,298 )
    


 


 


 


Net unrealized gains (losses)

     56,298       (8,440 )     8,296       59,407  

Currency translation adjustments, net of taxes

     (289 )     (2,750 )     (1,000 )     3,975  
    


 


 


 


Total Other Comprehensive Income (Loss)

     56,009       (11,190 )     7,296       63,382  
    


 


 


 


Comprehensive Income (Loss)

   $ 69,834     $ (27,723 )   $ 122,434     $ 142,137  
    


 


 


 


NET INCOME (LOSS) PER SHARE

                                

Basic

   $ 1.40     $ (1.68 )   $ 11.69     $ 8.00  

Diluted

   $ 1.40     $ (1.68 )   $ 11.68     $ 7.99  
    


 


 


 


 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Changes in Shareholders’ Equity

 

     Nine Months Ended
September 30,


 
     2004

    2003

 
     (dollars in thousands)  

COMMON STOCK

                

Balance at beginning of period

   $ 737,356     $ 736,246  

Issuance of common stock and other equity transactions

     4,622       798  
    


 


Balance at end of period

   $ 741,978     $ 737,044  
    


 


RETAINED EARNINGS

                

Balance at beginning of period

   $ 375,041     $ 251,568  

Net income

     115,138       78,755  

Repurchase of common stock

     (3,385 )     (1 )
    


 


Balance at end of period

   $ 486,794     $ 330,322  
    


 


ACCUMULATED OTHER COMPREHENSIVE INCOME

                

Unrealized gains:

                

Balance at beginning of period

   $ 270,819     $ 179,170  

Net unrealized holding gains arising during the period, net of taxes

     8,296       59,407  
    


 


Balance at end of period

     279,115       238,577  

Cumulative translation adjustments:

                

Balance at beginning of period

     (937 )     (7,873 )

Currency translation adjustments, net of taxes

     (1,000 )     3,975  
    


 


Balance at end of period

     (1,937 )     (3,898 )
    


 


Balance at end of period

   $ 277,178     $ 234,679  
    


 


SHAREHOLDERS’ EQUITY AT END OF PERIOD

   $ 1,505,950     $ 1,302,045  
    


 


 

See accompanying notes to consolidated financial statements.

 

5


Table of Contents

MARKEL CORPORATION AND SUBSIDIARIES

 

Consolidated Statements of Cash Flows

 

     Nine Months Ended
September 30,


 
     2004

    2003

 
     (dollars in thousands)  

OPERATING ACTIVITIES

                

Net Income

   $ 115,138     $ 78,755  

Adjustments to reconcile net income to net cash provided by operating activities

     378,747       371,997  
    


 


Net Cash Provided By Operating Activities

     493,885       450,752  
    


 


INVESTING ACTIVITIES

                

Proceeds from sales of fixed maturities and equity securities

     2,066,299       3,398,346  

Proceeds from maturities, calls and prepayments of fixed maturities

     158,575       185,442  

Cost of fixed maturities and equity securities purchased

     (2,690,032 )     (4,141,915 )

Net change in short-term investments

     (123,521 )     (36,212 )

Other

     (5,447 )     (3,294 )
    


 


Net Cash Used By Investing Activities

     (594,126 )     (597,633 )
    


 


FINANCING ACTIVITIES

                

Additions to senior long-term debt

     196,816       247,282  

Repayments and repurchases of senior long-term debt

     (110,000 )     (175,000 )

Repurchase of common stock

     (3,385 )     (1 )

Other

     922       798  
    


 


Net Cash Provided By Financing Activities

     84,353       73,079  
    


 


Decrease in cash and cash equivalents

     (15,888 )     (73,802 )

Cash and cash equivalents at beginning of period

     372,511       444,236  
    


 


CASH AND CASH EQUIVALENTS AT END OF PERIOD

   $ 356,623     $ 370,434  
    


 


 

See accompanying notes to consolidated financial statements.

 

6


Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. Principles of Consolidation

 

The consolidated balance sheet as of September 30, 2004, the related consolidated statements of operations and comprehensive income (loss) for the quarters and nine months ended September 30, 2004 and 2003, the consolidated statements of changes in shareholders’ equity and the consolidated statements of cash flows for the nine months ended September 30, 2004 and 2003, are unaudited. In the opinion of management, all adjustments necessary for fair presentation of such consolidated financial statements have been included. Such adjustments consist only of normal recurring items. Interim results are not necessarily indicative of results of operations for the full year. The consolidated balance sheet as of December 31, 2003 was derived from the Company’s audited annual consolidated financial statements.

 

The consolidated financial statements and notes are presented as permitted by Form 10-Q, and do not contain certain information included in the Company’s annual consolidated financial statements and notes. Readers are urged to review the Company’s 2003 annual report on Form 10-K for a more complete description of the Company’s business and accounting policies.

 

Certain reclassifications of prior year’s amounts have been made to conform with 2004 presentations.

 

2. Net Income (Loss) Per Share

 

Net income (loss) per share was determined by dividing net income (loss) by the applicable shares outstanding (in thousands):

 

     Quarter Ended
September 30,


    Nine Months Ended
September 30,


     2004

   2003

    2004

   2003

Net income (loss), as reported (basic and diluted)

   $ 13,825    $ (16,533 )   $ 115,138    $ 78,755
    

  


 

  

Average common shares outstanding

     9,847      9,845       9,850      9,841

Dilutive potential common shares

     7      —         5      18
    

  


 

  

Average diluted shares outstanding

     9,854      9,845       9,855      9,859
    

  


 

  

 

3. Stock Compensation Plans

 

The Company applies the intrinsic value recognition and measurement principles of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations, in accounting for stock-based compensation plans. The Company has adopted the disclosure-only provisions of Financial Accounting Standards Board Statement (Statement) No. 123, Accounting for Stock-Based Compensation, as amended.

 

Stock-based compensation cost, net of taxes, included in net income (loss) under APB Opinion No. 25 was $0.2 million and $0.9 million, respectively, for the quarter and nine months ended September 30, 2004 and $0.1 million and $0.5 million, respectively, for the same periods in 2003. Under the fair value method principles of Statement No. 123, pro forma stock-based compensation cost, net of taxes, and pro forma net income (loss) would not have differed from reported amounts for the quarters and nine months ended September 30, 2004 and 2003.

 

7


Table of Contents

4. Reinsurance

 

The table below summarizes the effect of reinsurance on premiums written and earned (dollars in thousands):

 

     Quarter Ended September 30,

 
     2004

    2003

 
     Written

    Earned

    Written

    Earned

 

Direct

   $ 617,669     $ 605,395     $ 645,600     $ 595,705  

Assumed

     22,102       38,413       25,834       29,578  

Ceded

     (114,366 )     (121,823 )     (147,650 )     (149,288 )
    


 


 


 


Net premiums

   $ 525,405     $ 521,985     $ 523,784     $ 475,995  
    


 


 


 


     Nine Months Ended September 30,

 
     2004

    2003

 
     Written

    Earned

    Written

    Earned

 

Direct

   $ 1,796,525     $ 1,811,796     $ 1,814,409     $ 1,707,705  

Assumed

     140,880       117,506       120,616       92,379  

Ceded

     (356,068 )     (386,499 )     (460,407 )     (452,863 )
    


 


 


 


Net premiums

   $ 1,581,337     $ 1,542,803     $ 1,474,618     $ 1,347,221  
    


 


 


 


 

Incurred losses and loss adjustment expenses are net of reinsurance recoverables (ceded incurred losses and loss adjustment expenses) of $102.1 million and $56.3 million, respectively, for the quarters ended September 30, 2004 and 2003 and $246.2 million and $156.4 million, respectively, for the nine months ended September 30, 2004 and 2003.

 

5. Junior Subordinated Deferrable Interest Debentures (8.71% Junior Subordinated Debentures)

 

On January 8, 1997, the Company arranged the sale of $150 million of Company-Obligated Mandatorily Redeemable Preferred Capital Securities (8.71% Capital Securities) issued under an Amended and Restated Declaration of Trust dated January 13, 1997 (the Declaration) by Markel Capital Trust I (the Trust), a statutory business trust sponsored and wholly-owned by the Company. Proceeds from the sale of the 8.71% Capital Securities were used to purchase the Company’s 8.71% Junior Subordinated Debentures due January 1, 2046, issued to the Trust under an indenture dated January 13, 1997 (the Indenture). The 8.71% Junior Subordinated Debentures are the sole assets of the Trust. The Company has the right to defer interest payments on the 8.71% Junior Subordinated Debentures for up to five years. The 8.71% Capital Securities and related 8.71% Junior Subordinated Debentures are redeemable by the Company on or after January 1, 2007. Taken together, the Company’s obligations under the Debentures, the Indenture, the Declaration and a guarantee made by the Company provide, in the aggregate, a full, irrevocable and unconditional guarantee of payments of distributions and other amounts due on the 8.71% Capital Securities. No other subsidiary of the Company guarantees the 8.71% Junior Subordinated Debentures or the 8.71% Capital Securities. In the event of default under the Indenture, the Trust may not make distributions on, or repurchases of, the Trust’s common securities. During a period in which the Company elects to defer interest payments or in the event of default under the Indenture, the Company may not make distributions on, or repurchases of, the Company’s capital stock or debt securities ranking equal or junior to the 8.71% Junior Subordinated Debentures.

 

8


Table of Contents

6. Convertible Notes Payable

 

During 2001, the Company issued $408.0 million principal amount at maturity, $112.9 million net proceeds, of Liquid Yield Option Notes (LYONs). The LYONs are zero coupon senior notes convertible into the Company’s common shares under certain conditions, with an initial conversion price of $243.53 per common share. The issue price of $283.19 per LYON represented a yield to maturity of 4.25%. The LYONs mature on June 5, 2031. The Company uses the effective yield method to recognize the accretion of discount from the issue price to the face amount of the LYONs at maturity. The accretion of discount is included in interest expense.

 

The Company’s potential obligation to accrue contingent additional principal terminated in accordance with the terms of the LYONs on June 5, 2004.

 

The Company will pay contingent cash interest to the holders of the LYONs during the six-month period commencing June 5, 2006 and during any six-month period thereafter if the average market price of a LYON for a specified period equals or exceeds 120% of the sum of the issue price and accrued original issue discount of the LYON.

 

Each LYON will be convertible into 1.1629 shares of common stock upon the occurrence of any of the following events: if the closing price of the Company’s common shares on the New York Stock Exchange exceeds specified levels, if the credit rating of the LYONs is reduced below specified levels, if the Company calls the LYONs for redemption, or if the Company is party to certain mergers or consolidations. The shares that would be issued if the LYONs were converted are not included in the Company’s calculation of diluted earnings per share for the quarter and nine months ended September 30, 2004 and 2003, as none of the conversion events had occurred. See Note 13 for discussion of a recently issued accounting pronouncement regarding contingently convertible instruments.

 

LYONs holders have the right to require the Company to repurchase the LYONs on June 5th of 2006, 2011, 2016, 2021 and 2026 at their accreted value on these dates as follows:

 

June 5, 2006

   $ 349.46

June 5, 2011

   $ 431.24

June 5, 2016

   $ 532.16

June 5, 2021

   $ 656.69

June 5, 2026

   $ 810.36

 

The Company may choose to pay the purchase price for such repurchases in cash or common shares of the Company. The Company may redeem the LYONs for cash on or after June 5, 2006 at their accreted value.

 

7. Unsecured Senior Notes

 

On August 13, 2004, the Company issued $200 million of 7.35% unsecured senior notes due August 15, 2034. The unsecured senior notes were issued under an existing shelf registration statement. Net proceeds to the Company were $196.8 million and were primarily used to repay $110.0 million outstanding under the Company’s revolving credit facility.

 

9


Table of Contents

8. Comprehensive Income (Loss)

 

Other comprehensive income (loss) is primarily composed of net holding gains (losses) on securities arising during the period less reclassification adjustments for gains (losses) included in net income (loss). Other comprehensive income (loss) also includes foreign currency translation adjustments. The related tax expense (benefit) on net holding gains (losses) on securities arising during the period was $30.2 million and $6.9 million, respectively, for the quarter and nine months ended September 30, 2004 and $(7.1) million and $44.5 million, respectively, for the same periods in 2003. The related tax expense (benefit) on the reclassification adjustments for gains (losses) included in net income (loss) was $(0.1) million and $2.4 million, respectively, for the quarter and nine months ended September 30, 2004 and $(2.6) million and $12.5 million, respectively, for the same periods in 2003. The related tax expense (benefit) on foreign currency translation adjustments was $(0.2) million and $(0.5) million, respectively, for the quarter and nine months ended September 30, 2004 and $(1.5) million and $2.1 million, respectively, for the same periods in 2003.

 

9. Segment Reporting Disclosures

 

The Company operates in three segments of the specialty insurance marketplace: the Excess and Surplus Lines, the Specialty Admitted and the London markets.

 

All investing activities are included in the Investing segment. Discontinued programs and non-strategic insurance subsidiaries are included in Other for purposes of segment reporting.

 

The Company considers many factors, including the nature of the underwriting units’ insurance products, production sources, distribution strategies and regulatory environment in determining how to aggregate operating segments.

 

Segment profit or (loss) for each of the Company’s operating segments is measured by underwriting profit or (loss). The property and casualty insurance industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) as a measure of profitability. Underwriting profit or (loss) provides a basis for management to evaluate the Company’s underwriting performance. Segment profit for the Investing segment is measured by net investment income and net realized gains or losses.

 

The Company does not allocate assets to the Excess and Surplus Lines, Specialty Admitted and London Insurance Market operating segments for management reporting purposes. The total investment portfolio, cash and cash equivalents are allocated to the Investing segment. The Company does not allocate capital expenditures for long-lived assets to any of its operating segments for management reporting purposes.

 

10


Table of Contents

a) Following is a summary of segment disclosures (dollars in thousands):

 

Quarter Ended September 30, 2004

 

     Excess and
Surplus Lines


    Specialty
Admitted


    London
Insurance
Market


    Investing

    Other

    Consolidated

 

Gross premium volume

   $ 374,137     $ 89,953     $ 170,467     $ —       $ 5,214     $ 639,771  

Net premiums written

     292,134       85,312       142,906       —         5,053       525,405  

Earned premiums

   $ 290,842     $ 68,632     $ 152,145     $ —       $ 10,366     $ 521,985  

Losses and loss adjustment expenses

     180,972       41,865       148,304       —         10,661       381,802  

Underwriting, acquisition and insurance expenses

     84,839       18,855       61,849       —         3,712       169,255  
    


 


 


 


 


 


Underwriting profit (loss)

     25,031       7,912       (58,008 )     —         (4,007 )     (29,072 )
    


 


 


 


 


 


Net investment income

     —         —         —         51,222       —         51,222  

Net realized losses from investment sales

     —         —         —         (253 )     —         (253 )
    


 


 


 


 


 


Segment profit (loss)

   $ 25,031     $ 7,912     $ (58,008 )   $ 50,969     $ (4,007 )   $ 21,897  
    


 


 


 


 


 


Interest expense

                                             14,495  
                                            


Income before income taxes

                                           $ 7,402  
                                            


U.S. GAAP combined ratio*

     91 %     89 %     138 %     —         139 %     106 %

 

Quarter Ended September 30, 2003

 

     Excess and
Surplus Lines


    Specialty
Admitted


    London
Insurance
Market


    Investing

    Other

    Consolidated

 

Gross premium volume

   $ 398,581     $ 81,095     $ 183,184     $ —       $ 8,574     $ 671,434  

Net premiums written

     291,435       76,991       150,257       —         5,101       523,784  

Earned premiums

   $ 266,800     $ 60,467     $ 140,538     $ —       $ 8,190     $ 475,995  

Losses and loss adjustment expenses

     185,107       37,892       93,137       —         62,732       378,868  

Underwriting, acquisition and insurance expenses

     80,191       16,494       49,046       —         1,371       147,102  
    


 


 


 


 


 


Underwriting profit (loss)

     1,502       6,081       (1,645 )     —         (55,913 )     (49,975 )
    


 


 


 


 


 


Net investment income

     —         —         —         46,379       —         46,379  

Net realized losses from investment sales

     —         —         —         (7,360 )     —         (7,360 )
    


 


 


 


 


 


Segment profit (loss)

   $ 1,502     $ 6,081     $ (1,645 )   $ 39,019     $ (55,913 )   $ (10,956 )

Interest expense

                                             13,720  
                                            


Loss before income taxes

                                           $ (24,676 )
                                            


U.S. GAAP combined ratio*

     99 %     90 %     101 %     —         783 %     110 %

 

11


Table of Contents

Nine Months Ended September 30, 2004

 

    

Excess and

Surplus Lines


    Specialty
Admitted


    London
Insurance
Market


    Investing

   Other

    Consolidated

 

Gross premium volume

   $ 1,114,808     $ 235,728     $ 548,139     $ —      $ 38,730     $ 1,937,405  

Net premiums written

     870,499       222,527       457,018       —        31,293       1,581,337  

Earned premiums

   $ 857,512     $ 196,373     $ 465,517     $ —      $ 23,401     $ 1,542,803  

Losses and loss adjustment expenses

     489,152       114,193       383,417       —        23,168       1,009,930  

Underwriting, acquisition and insurance expenses

     249,402       59,578       171,243       —        10,788       491,011  
    


 


 


 

  


 


Underwriting profit (loss)

     118,958       22,601       (89,143 )     —        (10,555 )     41,861  
    


 


 


 

  


 


Net investment income

     —         —         —         147,910      —         147,910  

Net realized gains from investment sales

     —         —         —         6,937      —         6,937  
    


 


 


 

  


 


Segment profit (loss)

   $ 118,958     $ 22,601     $ (89,143 )   $ 154,847    $ (10,555 )   $ 196,708  
    


 


 


 

  


 


Interest expense

                                            40,317  
                                           


Income before income taxes

                                          $ 156,391  
                                           


U.S. GAAP combined ratio*

     86 %     88 %     119 %     —        145 %     97 %

 

Nine Months Ended September 30, 2003

 

     Excess and
Surplus Lines


    Specialty
Admitted


    London
Insurance
Market


    Investing

   Other

    Consolidated

 

Gross premium volume

   $ 1,135,992     $ 212,533     $ 548,762     $ —      $ 37,738     $ 1,935,025  

Net premiums written

     812,910       199,778       435,846       —        26,084       1,474,618  

Earned premiums

   $ 750,716     $ 172,541     $ 404,753     $ —      $ 19,211     $ 1,347,221  

Losses and loss adjustment expenses

     480,667       105,824       268,742       —        83,587       938,820  

Underwriting, acquisition and insurance expenses

     211,878       54,908       143,977       —        10,132       420,895  
    


 


 


 

  


 


Underwriting profit (loss)

     58,171       11,809       (7,966 )     —        (74,508 )     (12,494 )
    


 


 


 

  


 


Net investment income

     —         —         —         137,079      —         137,079  

Net realized gains from investment sales

     —         —         —         35,843      —         35,843  
    


 


 


 

  


 


Segment profit (loss)

   $ 58,171     $ 11,809     $ (7,966 )   $ 172,922    $ (74,508 )   $ 160,428  
    


 


 


 

  


 


Amortization of intangible assets

                                            4,127  

Interest expense

                                            38,756  
                                           


Income before income taxes

                                          $ 117,545  
                                           


U.S. GAAP combined ratio*

     92 %     93 %     102 %     —        488 %     101 %

 

* The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums.

 

12


Table of Contents
b) The following summary reconciles segment assets to the Company’s consolidated financial statements (dollars in thousands):

 

     As of

     September 30,
2004


  

December 31,

2003


Segment Assets

             

Investing

   $ 5,918,506    $ 5,349,952

Other

     3,175,997      3,182,281
    

  

Total Assets

   $ 9,094,503    $ 8,532,233

 

10. Income Taxes

 

During the quarter ended September 30, 2004, the Company’s 2000 federal income tax year was closed. As a result, management determined that tax liabilities were $22.5 million less than previously estimated. The Company recognized a nonrecurring tax benefit of $4.1 million, reduced goodwill related to the Markel International acquisition by $14.7 million and increased additional paid in capital related to closed stock option plans by $3.7 million.

 

11. Goodwill and Other Intangible Assets

 

Statement No. 142, Goodwill and Other Intangible Assets, requires goodwill to be tested at least annually for impairment. The Company completes its annual test during the fourth quarter of each year based upon the results of operations through September 30. There was no indication of goodwill impairment as of September 30, 2004 or December 31, 2003.

 

Intangible assets other than goodwill were fully amortized as of June 30, 2003. The amortization expense for intangible assets was $4.1 million for the nine months ended September 30, 2003.

 

The carrying amounts of goodwill by reporting unit at September 30, 2004 were as follows: Excess and Surplus Lines, $81.8 million, and London Insurance Market, $260.8 million. The carrying amounts of goodwill by reporting unit at December 31, 2003 were as follows: Excess and Surplus Lines, $81.8 million, and London Insurance Market, $275.5 million. The carrying amount of goodwill for the London Insurance Market was reduced in the third quarter of 2004 by $14.7 million as discussed in Note 10.

 

12. Contingencies

 

On January 31, 2001, the Company received notice of a lawsuit filed in the United States District Court of the Southern District of New York against Terra Nova Insurance Company Limited by Palladium Insurance Limited and Bank of America, N.A. seeking approximately $27 million plus exemplary damages in connection with alleged reinsurance agreements. The discovery phase of this matter recently ended. The case is not expected to be ready for trial before 2005. The Company believes it has numerous defenses to this claim, including the defense that the alleged reinsurance agreements and insurance policies were not valid. The Company intends to vigorously defend this matter.

 

This and other contingencies arise in the normal conduct of the Company’s operations. In the opinion of management, the resolutions of these contingencies are not expected to have a material impact on the Company’s financial condition or results of operations. However, adverse outcomes are possible and could negatively impact the Company’s financial condition or results of operations.

 

13


Table of Contents

13. Recently Issued Accounting Pronouncement

 

In September 2004, the Financial Accounting Standards Board’s Emerging Issues Task Force (EITF) reached a consensus on EITF Issue No. 04-8 (Issue No. 04-8) which addresses the effect of contingently convertible instruments on diluted earnings per share. The Company’s convertible notes payable are considered to be a contingently convertible instrument based upon the criteria established by Issue No. 04-8. When Issue No. 04-8 becomes effective, the Company will be required to restate previously reported diluted earnings per share. It is anticipated this rule will take effect during the fourth quarter of 2004. If the proposed accounting treatment for the convertible notes payable had been in effect at the end of the third quarter, the Company’s diluted earnings per share for the nine months ended September 30, 2004 would be further diluted by approximately 2%.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The accompanying consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include the accounts of Markel Corporation and all subsidiaries (the Company).

 

Critical Accounting Policies

 

Critical accounting policies are defined as those that are both important to the portrayal of the Company’s financial condition and results of operations and require management to exercise significant judgment. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of material contingent assets and liabilities, including litigation contingencies, at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates, by necessity, are based on assumptions about numerous factors.

 

Management reviews its estimates and assumptions quarterly, including the adequacy of reserves for unpaid losses and loss adjustment expenses and reinsurance allowance for doubtful accounts, as well as the recoverability of deferred tax assets and intangible assets and the evaluation of the investment portfolio for other than temporary declines in value. Actual results may differ materially from the estimates and assumptions used in preparing the consolidated financial statements.

 

Readers are urged to review the Company’s 2003 annual report on Form 10-K for a more complete description of the Company’s critical accounting policies.

 

The Company

 

The Company markets and underwrites specialty insurance products and programs to a variety of niche markets. In each of these markets, the Company seeks to be a market leader. The financial goals of the Company are to earn consistent underwriting profits and superior investment returns to build shareholder value.

 

The Company competes in three segments of the specialty insurance marketplace: the Excess & Surplus Lines, the Specialty Admitted and the London markets. The Excess and Surplus Lines segment is comprised of five underwriting units, the Specialty Admitted segment consists of two underwriting units and the London Insurance Market segment is comprised of the ongoing operations of Markel International.

 

14


Table of Contents

The Excess and Surplus Lines segment writes property and casualty insurance for non-standard and hard-to-place risks including catastrophe-exposed property, professional liability, products liability, general liability, commercial umbrella and other coverages tailored for unique exposures.

 

The Specialty Admitted segment writes risks that are unique and hard-to-place in the standard market but must remain with an admitted insurance company for marketing and regulatory reasons. The underwriting units in this segment write specialty program insurance for well-defined niche markets and personal and commercial property and liability coverages.

 

The Company participates in the London market through Markel Capital Limited and Markel International Insurance Company Limited, two wholly-owned subsidiaries. Markel Capital Limited is the corporate capital provider for Markel Syndicate 3000 at Lloyd’s. Markel Syndicate Management Limited, a wholly-owned subsidiary, manages the Company’s Lloyd’s operations. The London Insurance Market segment writes specialty property, casualty, marine and aviation insurance and reinsurance.

 

Discontinued lines of business and non-strategic insurance subsidiaries are included in Other for segment reporting purposes. Other consisted primarily of discontinued Markel International programs and Corifrance, a wholly-owned subsidiary, for the quarters and nine months ended September 30, 2004 and 2003.

 

Results of Operations

 

The following information presents results of operations for the quarter and nine months ended September 30, 2004 compared to the quarter and nine months ended September 30, 2003.

 

Underwriting Results

 

Following is a comparison of selected data from the Company’s operations (dollars in thousands):

 

     Quarter Ended
September 30,


    Nine Months Ended
September 30,


 
     2004

    2003

    2004

    2003

 

Gross premium volume

   $ 639,771     $ 671,434     $ 1,937,405     $ 1,935,025  

Net premiums written

     525,405       523,784       1,581,337       1,474,618  

Net retention

     82 %     78 %     82 %     76 %

Earned premiums

     521,985       475,995       1,542,803       1,347,221  

Losses and loss adjustment expenses

     381,802       378,868       1,009,930       938,820  

Underwriting, acquisition and insurance expenses

     169,255       147,102       491,011       420,895  

Underwriting profit (loss)*

     (29,072 )     (49,975 )     41,861       (12,494 )
    


 


 


 


U.S. GAAP Combined Ratios

                                

Excess and Surplus Lines

     91 %     99 %     86 %     92 %

Specialty Admitted

     89 %     90 %     88 %     93 %

London Insurance Market

     138 %     101 %     119 %     102 %

Other

     139 %     783 %     145 %     488 %

Markel Corporation (Consolidated)

     106 %     110 %     97 %     101 %
    


 


 


 


 

* See note 9 of the notes to consolidated financial statements for a discussion of underwriting profit or (loss) and a reconciliation of this amount to income (loss) before income taxes. The property and casualty insurance

 

15


Table of Contents

industry commonly defines underwriting profit or (loss) as earned premiums net of losses and loss adjustment expenses and underwriting, acquisition and insurance expenses. Underwriting profit or (loss) does not replace operating income (loss) or net income (loss) computed in accordance with U.S. GAAP as a measure of profitability.

 

Underwriting profits are a key component of the Company’s strategy to grow book value per share. The Company believes that the ability to achieve consistent underwriting profits demonstrates knowledge and expertise, commitment to superior customer service and the ability to manage insurance risk. The Company uses underwriting profit or (loss) as a basis of evaluating its underwriting performance.

 

The U.S. GAAP combined ratio is a measure of underwriting performance and represents the relationship of incurred losses, loss adjustment expenses and underwriting, acquisition and insurance expenses to earned premiums. A combined ratio of less than 100% indicates an underwriting profit, while a combined ratio of greater than 100% reflects an underwriting loss.

 

The Company reported a combined ratio of 106% and 97%, respectively, for the quarter and nine months ended September 30, 2004 compared to a combined ratio of 110% and 101%, respectively, for the same periods in 2003. For the quarter and nine months ended September 30, 2004, the improved underwriting performance for the Excess and Surplus Lines and Specialty Admitted segments was partially offset by loss development in the London Insurance Market segment. The third quarter and nine month results for 2004 reflected approximately $80 million of pre-tax net losses related to Hurricanes Charley, Frances, Ivan and Jeanne.

 

The combined ratios for the Excess and Surplus Lines segment improved for both the quarter and nine months ended September 30, 2004 and included approximately $26 million of net losses related to the 2004 hurricanes. The improvement for both periods was due to more favorable development of prior years’ loss reserves in 2004 compared to 2003. In 2003, underwriting results included a $50 million increase in prior years’ loss reserves at the Investors Brokered Excess and Surplus Lines unit.

 

The Specialty Admitted segment produced improved underwriting results for the quarter and nine months ended September 30, 2004 compared to the same periods of 2003. The combined ratios for the quarter and nine months ended September 30, 2004 included approximately $9 million of net losses from the 2004 hurricanes. The Specialty Admitted segment continues to benefit from lower current year losses, more favorable development of prior years’ loss reserves and lower expense ratios.

 

The London Insurance Market segment’s combined ratios for the quarter and nine months ended September 30, 2004 included approximately $45.0 million of net losses for the 2004 hurricanes and an $8.0 million provision for dispute resolution. The underwriting loss for the nine months ended September 30, 2004 also included $30.0 million of loss reserve increases reported during the first quarter of 2004.

 

The underwriting loss from Other was $4.0 million for the quarter ended September 30, 2004 compared to $55.9 million for 2003. The Other underwriting loss for the nine months ended September 30, 2004 was $10.6 million compared to $74.5 million for the same period of 2003. During the third quarter of 2004, the Company completed a review of asbestos and environmental exposures in both its U.S. and international operations. While the legal environment and process for resolving asbestos and environmental claims continues to be adverse, no adjustments to loss reserves resulted from this review. The third quarter of 2003 included $55.0 million of reserve increases for asbestos and environmental exposures. Asbestos and environmental reserves are subject to significant uncertainty due to potential loss severity and frequency resulting from the uncertain and

 

16


Table of Contents

unfavorable legal climate. The Company seeks to establish appropriate reserve levels for asbestos and environmental exposures; however, these reserves could be subject to increases in the future.

 

Premiums

 

Following is a comparison of gross premium volume by significant underwriting segment:

 

Gross Premium Volume

 

Quarter Ended September 30,

         Nine Months Ended September 30,

2004

   2003

    

(dollars in thousands)


  2004

   2003

$ 374,137    $ 398,581      Excess and Surplus Lines   $ 1,114,808    $ 1,135,992
  89,953      81,095      Specialty Admitted     235,728      212,533
  170,467      183,184      London Insurance Market     548,139      548,762
  5,214      8,574      Other     38,730      37,738


  

    
 

  

$ 639,771    $ 671,434      Total   $ 1,937,405    $ 1,935,025


  

    
 

  

 

Gross written premium for the third quarter of 2004 declined 5% compared to the same period of 2003. For the nine months ended September 30, 2004, gross written premium was flat compared to 2003. The Company has experienced some market pressure to reduce prices in select lines of business on both new and renewal accounts. When the Company believes the prevailing market rates will not support its underwriting profit targets, the business is not written. The Company will not sacrifice underwriting profits to achieve top line growth and expects 2004 gross premium volume to be flat or slightly down compared to 2003.

 

Following is a comparison of earned premiums by significant underwriting segment:

 

Earned Premiums

 

Quarter Ended September 30,

         Nine Months Ended September 30,

2004

   2003

    

(dollars in thousands)


  2004

   2003

$ 290,842    $ 266,800      Excess and Surplus Lines   $ 857,512    $ 750,716
  68,632      60,467      Specialty Admitted     196,373      172,541
  152,145      140,538      London Insurance Market     465,517      404,753
  10,366      8,190      Other     23,401      19,211


  

    
 

  

$ 521,985    $ 475,995      Total   $ 1,542,803    $ 1,347,221


  

    
 

  

 

Earned premium for the third quarter and nine months ended September 30, 2004 increased 10% and 15%, respectively, compared to the same periods of 2003. This increase in both periods of 2004 is due to higher gross premium volume over the past two years and higher retentions compared to 2003 in all segments.

 

Net Retention

 

The Company purchases reinsurance in order to reduce its retention on individual risks and to enable it to write policies with sufficient limits to meet policyholder needs. The Company’s underwriting philosophy seeks to offer products with limits that do not require significant amounts of reinsurance. Net written premium was $525.4 million for the third quarter of 2004 compared to $523.8 million for the same period of 2003. For the nine months ended September 30, 2004, net written premium was $1.6 billion compared to $1.5 billion in 2003. Net retention of gross written premium has increased, consistent with the Company’s strategy to retain more of its underwriting profits. Net retention of gross written premium for the third quarter of 2004 was 82% compared to 78% for 2003. For the nine months ended September 30, 2004 net retention of gross written premium was 82% compared to 76% for the same period of 2003. The increase was primarily due to changes in the mix of premium writings and purchasing less reinsurance in both the Excess and Surplus Lines and the London Insurance Market segments during 2004 compared to 2003.

 

17


Table of Contents

Investment Results

 

Third quarter 2004 net investment income was $51.2 million compared to $46.4 million in the prior year. Net investment income for the nine months ended September 30, 2004 was $147.9 million compared to $137.1 million in 2003. In both periods of 2004, a larger investment portfolio offset lower investment yields.

 

Net realized losses for the quarter ended September 30, 2004 were $0.3 million compared to $7.4 million in 2003. For the nine months ended September 30, 2004, net realized gains were $6.9 million compared to $35.8 million for the same period last year. Variability in the timing of realized and unrealized investment gains and losses is to be expected.

 

Net realized losses for the quarter ended September 30, 2004 included $1.5 million of realized losses resulting from the write down of two equity securities. For the nine months ended September 30, 2004, net realized gains were partially offset by $3.2 million of realized losses resulting from the write down of three equity securities to their estimated fair value. These securities were deemed by management to have a decline in value that was other than temporary. For the quarter ended September 30, 2003, management determined there were no securities with a decline in value that was other than temporary. For the nine months ended September 30, 2003, net realized gains were partially offset by $15.0 million of realized losses resulting from the write down of one fixed income security and five equity securities to their estimated fair value. At September 30, 2004, the Company held securities with gross unrealized losses of approximately $14.1 million, or significantly less than 1% of the Company’s total investments, cash and cash equivalents. At September 30, 2004, all of these securities were reviewed and the Company believes there were no indications of other than temporary impairment.

 

Other Expenses

 

During the quarter ended September 30, 2004, the Company’s 2000 federal income tax year was closed. As a result, management determined that tax liabilities were $22.5 million less than previously estimated. The Company recognized a nonrecurring tax benefit of $4.1 million, reduced goodwill related to the Markel International acquisition by $14.7 million and increased additional paid in capital related to closed stock option plans by $3.7 million. Without regard to the nonrecurring benefit, the Company’s estimated annual effective tax rate was 29% for the nine months ended September 30, 2004 compared to 33% for the same period in 2003. The Company’s estimated annual effective rate differs from the statutory tax rate of 35% primarily as a result of tax exempt investment income.

 

Comprehensive Income (Loss)

 

Comprehensive income was $69.8 million for the third quarter of 2004 compared to comprehensive loss of $27.7 million for the same period of 2003. The improvement was primarily due to an increase in the market value of the Company’s investment portfolio and higher net income as a result of improved underwriting performance in the third quarter of 2004 compared to the same period of 2003. For the nine months ended September 30, 2004, comprehensive income was $122.4 million compared to $142.1 million in 2003. The decrease in comprehensive income was due to lower unrealized gains on the investment portfolio for the nine months ended September 30, 2004 compared to the same period of 2003 partially offset by higher net income as a result of a return to consolidated underwriting profits in 2004. Comprehensive income for the third quarter of 2004 includes a $0.3 million loss from currency translation adjustments, net of taxes, compared to a loss of $2.8 million for the same period of 2003. For the nine months ended September 30, 2004, the loss from currency translation adjustments, net of taxes, was $1.0 million compared to a gain of $4.0 million for the same period in 2003. The Company attempts to match assets and liabilities in original currencies to mitigate the impact of currency volatility.

 

18


Table of Contents

Financial Condition

 

At September 30, 2004, the Company’s investment portfolio increased approximately 11% to $5.9 billion from $5.3 billion at December 31, 2003. The Company reported net unrealized gains, net of taxes, on its fixed maturity and equity investments of $279.1 million at September 30, 2004 compared to $270.8 million at December 31, 2003. The fair market values of equity securities were $1.1 billion and $968.8 million, respectively, and represented 18% of the total investment portfolio at both September 30, 2004 and December 31, 2003.

 

Net cash provided by operating activities was $493.9 million for the nine months ended September 30, 2004 compared to $450.8 million for the same period in 2003. The increase was primarily due to increased cash flows from the Company’s international operations for the nine months ended September 30, 2004 compared to same period of 2003.

 

For the nine months ended September 30, 2004, the Company reported net cash provided by financing activities of $84.4 million compared to $73.1 million in 2003. The net cash provided by financing activities during the nine months ended September 30, 2004 was primarily due to a debt issuance during the third quarter, partially offset by the repayment of the outstanding balance under the Company’s revolving credit facility and the repurchase of 12,000 shares of the Company’s common stock. These repurchases were made in anticipation of the future issuance of the Company’s common stock to satisfy grants of Restricted Stock Units made to directors and officers under the Markel Corporation Omnibus Incentive Plan. The net cash provided by financing activities during the nine months ended September 30, 2003 was primarily the result of debt issuances during the first and second quarters of 2003, partially offset by the repayment of the outstanding balance under the Company’s revolving credit facility.

 

Prior to December 31, 2004, the Company expects to reallocate capital and liabilities among and between certain wholly-owned subsidiaries of Markel International by means of commutation and reinsurance agreements between the subsidiaries. The Company anticipates this transaction may require a capital contribution to Markel International of approximately $70 million.

 

The Company has access to various liquidity sources including dividends from its insurance subsidiaries, holding company investments and cash, undrawn capacity under its revolving credit facility and access to the debt and equity capital markets. Management believes that the Company has sufficient liquidity to meet its needs.

 

Shareholders’ equity at September 30, 2004 was $1.5 billion compared to $1.4 billion at December 31, 2003. Book value increased 9% to $152.93 per share primarily as a result of $115.1 million of net income for the nine months ended September 30, 2004.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument as the result of changes in equity prices, interest rates, foreign exchange rates and commodity prices.

 

19


Table of Contents

The Company’s consolidated balance sheets include assets and liabilities with estimated fair values which are subject to market risk. The primary market risks to the Company are equity price risk associated with investments in equity securities, interest rate risk associated with investments in fixed maturities and foreign exchange risk for its international operations. The Company has no material commodity risk.

 

The Company primarily manages foreign exchange risk by matching assets and liabilities in each foreign currency as closely as possible. Significant estimations and assumptions are required when establishing insurance balances such as reinsurance recoverables and reserves for unpaid losses and loss adjustment expenses. As a result, matching of assets and liabilities by currency is subject to change as actual results emerge.

 

The Company’s market risks at September 30, 2004 have not materially changed from those identified at December 31, 2003.

 

Item 4. Controls and Procedures

 

As of the end of the period covered by this quarterly report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Chairman and Chief Executive Officer (CEO) and the Executive Vice President and Chief Financial Officer (CFO), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-15 (Disclosure Controls).

 

The Company’s management, including the CEO and CFO, does not expect that its Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Based upon the Company’s controls evaluation, the CEO and CFO have concluded that the Company’s Disclosure Controls provide reasonable assurance that the information required to be disclosed by the Company in its periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

 

There were no changes in the Company’s internal control over financial reporting during the Company’s most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Safe Harbor and Cautionary Statement

 

This is a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995. It also contains general cautionary statements regarding the Company’s business, estimates and management assumptions.

 

20


Table of Contents

Future actual results may materially differ from those in these statements because of many factors. Among other things:

 

The impact of the events of September 11, 2001 will depend on the number of insureds and reinsureds affected by the events, the amount and timing of losses incurred and reported and questions of how coverage applies;

 

The occurrence of additional terrorist activities could have a material impact on the Company and the insurance industry;

 

The Company’s anticipated premium volume is based on current knowledge and assumes no significant man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;

 

The Company is legally required to offer terrorism insurance and has attempted to manage its exposure; however, in the event of a covered terrorist attack, the Company could sustain material losses;

 

Changing legal and social trends and inherent uncertainties, including but not limited to those uncertainties associated with the Company’s asbestos and environmental reserves, in the loss estimation process can adversely impact the adequacy of loss reserves and the allowance for reinsurance recoverables;

 

Industry and economic conditions can affect the ability and/or willingness of reinsurers to pay balances due;

 

The Company continues to closely monitor discontinued lines and reinsurance programs and exposures. Adverse experience in these areas could lead to additional charges;

 

Regulatory actions can impede the Company’s ability to charge adequate rates and efficiently allocate capital; and

 

Economic conditions, interest rates and foreign exchange rate volatility and concentration of investments can have a significant impact on the market value of fixed maturity and equity investments, as well as the carrying value of other assets and liabilities.

 

The Company’s premium volume, underwriting and investment results have been and will continue to be potentially materially affected by these factors. Additional factors, which could affect the Company, are discussed in the Company’s reports on Forms 8-K, 10-Q and 10-K. By making these forward-looking statements, the Company is not intending to become obligated to publicly update or revise any forward-looking statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as at their dates.

 

PART II. OTHER INFORMATION

 

Item 6. Exhibits

 

See Exhibit Index for a list of Exhibits filed as part of this report.

 

21


Table of Contents

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized, this 3rd day of November, 2004.

 

The Company
By  

/s/ Alan I. Kirshner


    Alan I. Kirshner
    Chairman and Chief Executive Officer
    (Principal Executive Officer)
By  

/s/ Anthony F. Markel


    Anthony F. Markel
    President
    (Principal Operating Officer)
By  

/s/ Steven A. Markel


    Steven A. Markel
    Vice Chairman
By  

/s/ Darrell D. Martin


    Darrell D. Martin
    Executive Vice President and
    Chief Financial Officer
    (Principal Financial Officer and
    Principal Accounting Officer)

 

22


Table of Contents

Exhibit Index

 

Number

 

Description


    3(i)   Amended and Restated Articles of Incorporation, as amended (3(i))a
    3(ii)   Bylaws, as amended (4.2)b
    4   Credit Agreement dated September 30, 2003, among Markel Corporation, the lenders named therein and SunTrust Bank, as Administrative Agent (4)c
    The registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of all instruments defining the rights of holders of convertible notes payable and long-term debt of the registrant and subsidiaries shown on the Consolidated Balance Sheet of the registrant at September 30, 2004 and the respective Notes thereto, included in the Quarterly Report on Form 10-Q.
    31.1   Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)*
    31.2   Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)*
    32.1   Certification of Principal Executive Officer furnished Pursuant to 18 U.S.C. Section 1350*
    32.2   Certification of Principal Financial Officer furnished Pursuant to 18 U.S.C. Section 1350*

 

a. Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended March 31, 2000.
b. Incorporated by reference from Exhibit 4.2 to S-8 Registration Statement No. 333-107661, dated

August 5, 2003.

c. Incorporated by reference from the exhibit shown in parentheses filed with the Commission in the Registrant’s report on Form 10-Q for the quarter ended September 30, 2003.
* Filed with this report.

 

23